Diabetic retinopathy (DR) is the most common microangiopathic complication of diabetes
mellitus, representing a major cause of visual impairment in developed countries …

Background Diabetic macular oedema (DMO) is a common complication of diabetic
retinopathy. Although grid or focal laser photocoagulation has been shown to reduce the risk …

Aflibercept, bevacizumab or ranibizumab for diabetic macular... : Current Opinion in
Ophthalmology Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema …

Given the complexity of the current system used to stage diabetic retinopathy (DR) and the
risks and limitations associated with intravenous fluorescein angiography (IVFA) …

Fundus-controlled perimetry (FCP, also called 'microperimetry') allows for spatially-resolved
mapping of visual sensitivity and measurement of fixation stability, both in clinical practice as …

Importance Anti–vascular endothelial growth factor (VEGF) therapy is commonly used to
treat numerous retinal conditions and appears safe, yet controversy remains regarding …

Purpose: To evaluate the changes in foveal avascular zone (FAZ) area and the retinal
capillary density after a single intravitreal anti-VEGF injection for macular edema secondary …

Diabetic macular edema (DME) represents a prevalent and disabling eye condition. Despite
that DME represents a sight‐threatening condition, it is also among the most accessible to …

Endpoint development trials are underway across the spectrum of retinal disease. New
validated endpoints are urgently required for the assessment of emerging gene therapies …

Abstract Background/Objectives To study the mechanism of restoration of retinal
photoreceptor ellipsoid zone (EZ), after intravitreal bevacizumab (IVB) therapy, in diabetic …